Skip to Main Content
Table 1

Immunohistochemical analysis of ETAR, ETBR, and ET-1 expression in primary human breast carcinomas

Scoren (%)
ETAR (n = 159)ETBR (n = 161)ET-1 (n = 160)
0 39 (24.5) 37 (23) 31 (19.4) 
1+ 46 (28.9) 38 (23.6) 60 (37.5) 
2+ 46 (28.9) 38 (23.6) 44 (27.5) 
3+ 28 (17.6) 48 (29.8) 25 (15.6) 
Negative (score 0–1) 85 (53.5) 75 (46.6) 91 (56.9) 
Positive (score 2–3) 74 (46.5) 86 (53.4) 69 (43.1) 
Scoren (%)
ETAR (n = 159)ETBR (n = 161)ET-1 (n = 160)
0 39 (24.5) 37 (23) 31 (19.4) 
1+ 46 (28.9) 38 (23.6) 60 (37.5) 
2+ 46 (28.9) 38 (23.6) 44 (27.5) 
3+ 28 (17.6) 48 (29.8) 25 (15.6) 
Negative (score 0–1) 85 (53.5) 75 (46.6) 91 (56.9) 
Positive (score 2–3) 74 (46.5) 86 (53.4) 69 (43.1) 
View Large
Close Modal
This Feature Is Available To Subscribers Only

or Create an Account

Close Modal
Close Modal
This site uses cookies. By continuing to use our website, you are agreeing to our privacy policy.
Accept